Biotech

All Articles

Zephyrm seeks Hong Kong IPO to money phase 3 tissue treatment tests

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, filing (PDF) for an IPO ...

Frazier Life Sciences gathers $630M for little, mid-cap biotechs

.Frazier Everyday life Sciences has actually sourced an even further $630 million for its fund paid ...

GigaGen garners up to $135M BARDA bucks to beat botulism

.Antibody connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its own specia...

GPCR organization Septerna declare IPO on stamina of preclinical records

.Septerna is about to figure out just how a biotech without "any type of meaningful scientific recor...

Kurma shuts initially $154M haul for largest biotech fund as yet

.International VC firm Kurma Partners has actually unveiled its own newest biotech fund, with 140 th...

Prothena promotes one director while one more places-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, firings an...

Editas exploit Vertex Cas9 licensing rights for $57M

.Against the background of a Cas9 patent struggle that refuses to die, Editas Medicine is moneying i...

Ultragenyx adjusts genetics therapy application to dial up efficiency

.A minority of clients taking Ultragenyx Drug's Wilson health condition genetics therapy UX701 have ...

Biopharma layoff cost maintains in Q3: Strong Biotech study

.As summer warmth turns to cool winds, hopes that this year would deliver prevalent business comfort...

J &amp J goes down period 2 dengue prospect in most up-to-date switch coming from vaccines

.Johnson &amp Johnson's deprioritization of its own transmittable health condition pipe has professe...